Jiangsu Alphamab, 3D Medicines and Glenmark sign license agreement for Envafolimab

Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America

Indian Red Cross Society and Cadila to launch training of 50,000 students for CPR and First Aid

The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state

Eiko LifeSciences inks business agreement with Vivacious Pharmatex

The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials

BenevolentAI appoints former Bayer R&D head Dr. Joerg Moeller as CEO

An accomplished R&D leader and champion of the application of AI to drug discovery

Lupin receives tentative USFDA approval for Rivaroxaban Tablets USP

Lupin receives USFDA’s approval for Febuxostat Tablets

Febuxostat Tablets (RLD Uloric) had estimated annual sales of US$ 27 million in the U.S. (IQVIA MAT November 2023)

Torque Pharma reinvents healthcare dynamics with 'Better Together'

The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme

Pharmatech Associates adds Dr. Praveen Tyle to Board of Trustees

Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India

Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa

NovaBay and Sonoma to market Avenova-branded products in EU through Sonoma’s distributor network

Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products